LT3334B - Process for preparing pharmacological composition - Google Patents

Process for preparing pharmacological composition Download PDF

Info

Publication number
LT3334B
LT3334B LTIP512A LTIP512A LT3334B LT 3334 B LT3334 B LT 3334B LT IP512 A LTIP512 A LT IP512A LT IP512 A LTIP512 A LT IP512A LT 3334 B LT3334 B LT 3334B
Authority
LT
Lithuania
Prior art keywords
bis
zinc
months
indole
solution
Prior art date
Application number
LTIP512A
Other languages
English (en)
Lithuanian (lt)
Inventor
Maria Gazdag
Gabor Szepesi
Geza Takacsy-Nagy
Zsofia Papp
Laszlo Nagy
Eva Eszter Kiss
Monika Zsoldos
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of LTIP512A publication Critical patent/LTIP512A/xx
Publication of LT3334B publication Critical patent/LT3334B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
LTIP512A 1989-11-07 1993-05-06 Process for preparing pharmacological composition LT3334B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895804A HU204995B (en) 1989-11-07 1989-11-07 Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes

Publications (2)

Publication Number Publication Date
LTIP512A LTIP512A (en) 1994-11-25
LT3334B true LT3334B (en) 1995-07-25

Family

ID=10970758

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP512A LT3334B (en) 1989-11-07 1993-05-06 Process for preparing pharmacological composition

Country Status (37)

Country Link
US (1) US5397784A (xx)
JP (1) JP3042702B2 (xx)
KR (1) KR0164601B1 (xx)
CN (1) CN1053569C (xx)
AR (1) AR245592A1 (xx)
AT (1) AT401469B (xx)
AU (1) AU638504B2 (xx)
BE (1) BE1004051A4 (xx)
BG (1) BG60609B1 (xx)
CA (1) CA2029368C (xx)
CH (1) CH682130A5 (xx)
CZ (1) CZ279433B6 (xx)
DE (1) DE4035253B4 (xx)
DK (1) DK266390A (xx)
ES (1) ES2026062A6 (xx)
FI (1) FI100455B (xx)
FR (1) FR2653998B1 (xx)
GB (1) GB2238241B (xx)
GR (1) GR1001041B (xx)
HU (1) HU204995B (xx)
IE (1) IE62387B1 (xx)
IL (1) IL96249A (xx)
IT (1) IT1242724B (xx)
LT (1) LT3334B (xx)
LV (1) LV10687B (xx)
MY (1) MY104595A (xx)
NL (1) NL9002412A (xx)
NO (1) NO175565C (xx)
NZ (1) NZ236005A (xx)
PL (1) PL164881B1 (xx)
PT (1) PT95810B (xx)
RU (1) RU1828401C (xx)
SE (1) SE509715C2 (xx)
SK (1) SK540290A3 (xx)
UA (1) UA13162A (xx)
YU (1) YU48373B (xx)
ZA (1) ZA908855B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
JP2002100303A (ja) * 2000-09-20 2002-04-05 Hitachi Ltd カラ−陰極線管
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US8512761B2 (en) 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
TWI678213B (zh) * 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619935A (en) 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU191538B (en) 1982-07-19 1987-03-30 Lilly Co Eli Process for producing pharmaceutical compositions containing acid additional salts of vinca-dimeres
EP0243278A1 (fr) 1986-04-25 1987-10-28 Pierre Fabre Medicament Solution aqueuse stable de sulfate de vincristine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (de) * 1980-07-31 1982-05-12 Uwe Olthoff Verfahren zur herstellung stabiler kalziumhaltiger injektionsloesungen
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191538B (en) 1982-07-19 1987-03-30 Lilly Co Eli Process for producing pharmaceutical compositions containing acid additional salts of vinca-dimeres
US4619935A (en) 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
EP0243278A1 (fr) 1986-04-25 1987-10-28 Pierre Fabre Medicament Solution aqueuse stable de sulfate de vincristine

Also Published As

Publication number Publication date
AU6584590A (en) 1991-05-16
CN1053569C (zh) 2000-06-21
HUT55225A (en) 1991-05-28
FI100455B (fi) 1997-12-15
GB2238241B (en) 1993-10-06
CN1053185A (zh) 1991-07-24
LTIP512A (en) 1994-11-25
GR900100795A (en) 1992-04-17
PT95810A (pt) 1991-09-13
IL96249A0 (en) 1991-08-16
SE9003523L (sv) 1991-05-08
GB2238241A (en) 1991-05-29
CA2029368C (en) 2000-01-04
HU204995B (en) 1992-03-30
US5397784A (en) 1995-03-14
BG60609B1 (bg) 1995-10-31
FI905508A0 (fi) 1990-11-07
SK278421B6 (en) 1997-05-07
NZ236005A (en) 1992-03-26
PT95810B (pt) 1997-11-28
NO175565C (no) 1994-11-02
CZ279433B6 (cs) 1995-04-12
NO904821L (no) 1991-05-08
YU48373B (sh) 1998-07-10
KR0164601B1 (ko) 1999-01-15
IE903993A1 (en) 1991-05-08
UA13162A (uk) 1997-02-28
PL164881B1 (en) 1994-10-31
LV10687B (en) 1995-12-20
NO904821D0 (no) 1990-11-06
CZ540290A3 (en) 1994-11-16
IT1242724B (it) 1994-05-17
ZA908855B (en) 1991-08-28
BE1004051A4 (fr) 1992-09-15
ES2026062A6 (es) 1992-04-01
CA2029368A1 (en) 1991-05-08
AR245592A1 (es) 1994-02-28
IT9067868A1 (it) 1992-05-06
FR2653998A1 (fr) 1991-05-10
GB9024222D0 (en) 1990-12-19
SE9003523D0 (sv) 1990-11-06
YU209590A (sh) 1993-05-28
DE4035253B4 (de) 2004-10-07
DE4035253A1 (de) 1991-05-08
NL9002412A (nl) 1991-06-03
FR2653998B1 (fr) 1995-02-17
GR1001041B (el) 1993-03-31
CH682130A5 (xx) 1993-07-30
ATA223090A (de) 1996-02-15
IT9067868A0 (it) 1990-11-06
KR910009245A (ko) 1991-06-28
IL96249A (en) 1995-07-31
AT401469B (de) 1996-09-25
SK540290A3 (en) 1997-05-07
NO175565B (no) 1994-07-25
SE509715C2 (sv) 1999-03-01
JP3042702B2 (ja) 2000-05-22
DK266390A (da) 1991-05-08
MY104595A (en) 1994-04-30
HU895804D0 (en) 1990-01-28
IE62387B1 (en) 1995-01-25
LV10687A (lv) 1995-06-20
RU1828401C (ru) 1993-07-15
DK266390D0 (da) 1990-11-06
JPH03206040A (ja) 1991-09-09
AU638504B2 (en) 1993-07-01

Similar Documents

Publication Publication Date Title
NZ321616A (en) Stable freeze-dried pharmaceutical formulation
SK281558B6 (sk) Injikovateľná kompozícia na prípravu infúzneho roztoku obsahujúca deriváty skupiny taxánov
KR20060096411A (ko) 테트로도톡신의 안정한 동결건조 제약 제제
DE102004063347A1 (de) Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
LT3334B (en) Process for preparing pharmacological composition
JP3129428B2 (ja) セファロスポリン系薬物を含有する注射用組成物
AU2004314154A1 (en) Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
KR20030068541A (ko) 산의 함량이 작고 저장 중에 안정한 시프로플록사신 주입물
US5496809A (en) Stable solutions of rebeccamycin analog
HU195513B (en) Process for producing stable solutions of alkaloides with bis-indole skeleton
KR100825572B1 (ko) 칼슘, 마그네슘 및 비타민을 포함하는 액제 조성물 및 그의제조방법
JPH08231403A (ja) アルギニンバソプレシン拮抗薬を含有する安定な水溶液
JP2536173B2 (ja) 注射剤
HU211477A9 (hu) Bisz-indol-alkaloid-sót tartalmazó injekciós oldat
DD292135A5 (de) Verfahren zur herstellung einer stabilen zusammensetzung von cisplatin fuer die parenterale verabreichung
KR20120030530A (ko) 이파모렐린 디아세테이트 주사 및 주입 용액
RU2095061C1 (ru) Фармацевтическая композиция
SI9012095A (sl) Injekcijska raztopina in postopek za njeno pridobivanje
AU1134500A (en) 'Soluble 2-chloro-2'-deoxyadenosine formulations'

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20070506